Ypsomed Holding AG

Equities

YPSN

CH0019396990

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 09:59:34 2024-04-19 am EDT 5-day change 1st Jan Change
380.8 CHF +0.20% Intraday chart for Ypsomed Holding AG +0.53% +26.07%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization MT
Dental Equipment Company Straumann Names New Chair MT
Gerresheimer expects sales boost from burgeoning obesity drugs sector RE
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says RE
Swiss Equities Rise as Economic Sentiment Further Brightens MT
Ypsomed to Sell Pen Needle, Glucose Monitoring Units Amid Increased Focus on Diabetes Care MT
MTD Medical Technology and Devices S.A. agreed to acquire the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG. CI
Octavian Downgrades Recommendation on Ypsomed to Hold From Buy MT
Switzerland's Sonova Names New Chair for 2025 Nomination MT
Ypsomed Holding AG Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Transcript : Ypsomed Holding AG, H1 2024 Earnings Call, Nov 15, 2023
Ypsomed Posts Growth in Fiscal H1 Net Profit, Sales MT
How Novo Nordisk makes its weight-loss drug Wegovy RE
Ypsomed to Customize, Supply Autoinjector Pen Device for Viridian Therapeutics MT
Viridian Therapeutics, Inc. Enters Autoinjector Pen Device Customization and Supply Agreement with Ypsomed Ag for Subcutaneous Drug Delivery in Thyroid Eye Disease CI
Ypsomed Signs Partnership to Offer Human Factor Services MT
Ypsomed Appoints Feintool CFO to Same Role MT
Health Care Climbs on Defensive Bias -- Health Care Roundup DJ
Novo Nordisk, Ypsomed Conclude Long-Term Autoinjector Supply Deal MT
Correction to Ypsomed Article DJ
Ypsomed to Supply Novo Nordisk With Autoinjectors DJ
Ypsomed signs autoinjector supply deal with Novo Nordisk RE
Ypsomed Signs Long-term Autoinjectors Supply Contract with Novo Nordisk MT
Dental implants maker Straumann reports H1 sales in line with expectations RE
SIX Group Makes Index Adjustments Following Review MT
Chart Ypsomed Holding AG
More charts
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
380 CHF
Average target price
365 CHF
Spread / Average Target
-3.95%
Consensus
  1. Stock Market
  2. Equities
  3. YPSN Stock
  4. News Ypsomed Holding AG
  5. Ypsomed CEO Expects Key Product Ypsopump To Break Even In Two Years